How Androgens Change Where PCOS Stores Fat — and Why Spot Reduction Fails

Why Does PCOS Push Fat Toward the Abdomen?

Intra-abdominal fat mass was significantly higher in women with normal-weight PCOS than in hormonally normal women of the same body mass index, according to a 2016 study — and that difference showed up even though neither group was carrying excess total body fat. The pattern people describe as “PCOS holds weight in the middle” is not really about total weight at all; it is about where the body chooses to store fat once androgen levels rise, and the evidence points at a specific mechanism rather than a vague hormonal fog.

Fat tissue is not one uniform substance. Different depots — the fat under the skin at the hips and thighs versus the fat packed around the abdominal organs — carry different densities of hormone receptors and respond differently to the same hormonal signal. A 2025 review of the adipose-androgen relationship in PCOS describes this as a two-way loop: androgens shift fat storage toward the abdominal, visceral depot, and that visceral fat then produces inflammatory signals and reduced adiponectin that make the ovary produce even more androgen. It is a loop that reinforces itself, not a single push in one direction.

What Does the Direct Evidence on Androgens and Belly Fat Show?

A 2016 study measured circulating hormones, insulin sensitivity and abdominal fat by MRI and biopsy in six women with normal-weight PCOS and 14 age- and BMI-matched women without it, and found intra-abdominal fat mass significantly higher in the PCOS group — and positively correlated with androgen levels, fasting insulin, triglycerides and non-HDL cholesterol across everyone in the study, not just the PCOS group. Subcutaneous abdominal fat mass was not significantly different between groups, but in the PCOS group it contained a higher proportion of small fat cells that also correlated with androgen levels.

Insulin resistance and androgens are not competing explanations — they run through the same loop. High insulin also lowers sex-hormone-binding globulin, which raises free testosterone in the blood, so the two mechanisms travel together in most people with PCOS. For what the imaging evidence shows about PCOS fat distribution overall, including where insulin resistance outweighs androgens as the stronger average driver, see the full breakdown.

Can You Target PCOS Lower Belly Fat With Exercise?

No — a 2011 randomized trial found that six weeks of dedicated abdominal exercise produced no significant change in abdominal fat, waist circumference, abdominal skinfold thickness or overall body fat percentage, even though the exercise group significantly improved their curl-up endurance compared to a no-exercise control group. That trial was not run in PCOS specifically — its 24 participants were healthy, sedentary adults, 14 men and 10 women — but the mechanism it tests is universal: muscles burn the fuel available to them from the whole-body circulation, not preferentially the fat sitting directly on top of that muscle.

This matters specifically for PCOS because so much lower-belly-fat advice online is built on the spot-reduction premise — an exercise, a wrap, a “waist trainer” — sold as a way to target the exact depot that androgens and insulin resistance push fat into. None of that machinery exists in human physiology. What changes visceral and abdominal fat is what changes the hormonal signal driving storage there in the first place, not which muscle group did the most reps that day.

Why Does PCOS Fat Go to the Middle Specifically?

Visceral fat cells in PCOS carry a different receptor profile than the subcutaneous fat at the hips and thighs, and that difference is the most direct answer to why the distribution — not just the amount — of fat changes. The 2025 adipose-androgen review describes androgens as favouring storage in the visceral depot partly through direct receptor action and partly by suppressing the enzyme activity that would otherwise clear fat from that depot, while oestrogen favours the gluteofemoral, hip-and-thigh pattern more typical outside of hyperandrogenic states. When androgen levels rise relative to oestrogen, the balance of that storage decision shifts toward the middle. High testosterone in women covers what actually counts as elevated and what commonly drives it, if you want the diagnostic side of this rather than the fat distribution consequence.

None of this means the visceral depot is inert once it forms. The 2025 review describes visceral fat as an active endocrine tissue in its own right once established — releasing inflammatory signals and reduced adiponectin that circle back to worsen both insulin resistance and ovarian androgen output. That is why this is described as a loop rather than a one-way cause: the fat distribution is a downstream effect of the hormonal picture, and once established it starts contributing back to that picture.

What Actually Changes Fat Distribution, If Not Spot Exercise?

Whole-body resistance and aerobic activity change fat distribution by improving insulin sensitivity system-wide, which is the mechanism with the strongest and most consistent PCOS evidence behind it — not by working the muscle nearest the fat you want to lose. The 2023 international PCOS guideline sets the same activity target used for the general population: 150 to 300 minutes of moderate-intensity activity a week, or 75 to 150 minutes vigorous, plus muscle-strengthening work on two non-consecutive days. That target exists because it moves the metabolic markers behind fat storage, not because any specific exercise reaches the abdominal depot directly.

Diet composition matters through the same insulin pathway rather than through any depot-specific mechanism — see PCOS weight change without exercise for what diet-only interventions actually moved in trials, and what they did not. What does not belong in this list is anything marketed as flushing, cleansing or “detoxing” fat from a specific area; PCOS ‘detox’ programmes breaks down why that framing has no physiological mechanism behind it at all, let alone a targeted one.

Who This Explanation Does Not Fit

Not everyone’s central fat is androgen-led, and it is worth saying plainly where this mechanism is a weaker fit. Some people with PCOS run normal or only mildly elevated androgens and still carry central fat — for that group, insulin resistance alone, or in some cases chronic stress and elevated cortisol, is doing more of the work than androgens are, and androgen-focused explanations will not match their experience. No published trial has directly tested whether lowering androgens with medication changes abdominal fat distribution as an outcome in itself, so that specific claim cannot be made here one way or the other — it is a real gap in the evidence, not an oversight.

You may also see this condition called polyendocrine metabolic ovarian syndrome (PMOS), the name a May 2026 global consensus of more than 50 medical organisations gave it in The Lancet. The mechanisms above are unchanged by the rename; this article uses PCOS because that is still what most readers search.